Advertisement
UK markets close in 1 hour 22 minutes
  • FTSE 100

    8,160.78
    +39.54 (+0.49%)
     
  • FTSE 250

    19,992.85
    +66.26 (+0.33%)
     
  • AIM

    766.93
    +1.95 (+0.25%)
     
  • GBP/EUR

    1.1683
    -0.0001 (-0.01%)
     
  • GBP/USD

    1.2483
    -0.0041 (-0.33%)
     
  • Bitcoin GBP

    46,981.75
    +1,060.76 (+2.31%)
     
  • CMC Crypto 200

    1,260.50
    -10.24 (-0.81%)
     
  • S&P 500

    5,020.97
    +2.58 (+0.05%)
     
  • DOW

    37,957.69
    +54.40 (+0.14%)
     
  • CRUDE OIL

    78.85
    -0.15 (-0.19%)
     
  • GOLD FUTURES

    2,301.50
    -9.50 (-0.41%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,207.13
    +444.10 (+2.50%)
     
  • DAX

    17,932.70
    +0.53 (+0.00%)
     
  • CAC 40

    7,936.58
    -48.35 (-0.61%)
     

Ultimovacs ASA – Annual General Meeting held on April 18, 2024

Ultimovacs ASA
Ultimovacs ASA

Oslo, April 18, 2023: Ultimovacs ASA held its annual general meeting today April 18, 2024. All the matters on the agenda were approved.

The following board members were re-elected for a period of one year, and the Board of Directors will consist of the following persons:

  • Jónas Einarsson, Chair of the Board

  • Henrik Schüssler, board member

  • Kari Grønås, board member

  • Ketil Fjerdingen, deputy board member

The Nomination Committee will consist of the following persons until the Annual General Meeting in 2025:

  • Ole Kristian Hjelstuen, Chair of the committee

  • Hans Peter Bøhn, committee member

The minutes from the meeting are enclosed and available at the company’s website.

ADVERTISEMENT

For further information, please see www.ultimovacs.com or contact:

Jónas Einarsson, Chair of the Board of Directors of Ultimovacs ASA

Email: je@radforsk.no

Phone: +47 480 96 355

Carlos de Sousa, CEO

Email: carlos.desousa@ultimovacs.com

Phone: +47 908 92507

        

Anne Worsøe, Head of IR & Communication

Email: anne.worsoe@ultimovacs.com

Phone: +47 906 86815


Attachment